Skip to main content
SpringerLink
Log in

The Role of Endoplasmic Reticulum Stress and NLRP3 Inflammasomes in the Development of Atherosclerosis

  • Published:
Cytology and Genetics Aims and scope Submit manuscript

Abstract

Endoplasmic reticulum (ER) plays a central role in the synthesis of proteins and their post-translational modification by folding newly synthesized proteins through the formation of disulfide bonds, which is necessary for their final stable conformational state. ER homeostasis is stressed when the influx of newly synthesized unfolded or misfolded polypeptide chains exceeds the ER capacity for repair and refolding. ER stress in diabetes can be caused by various factors that inhibit protein folding, such as glucose, nonesterified cholesterol, oxidized phospholipids, saturated fatty acids, and ROS. Chronic ER stress leads to the death of pancreatic β-cells, increases hyperglycemia, and is the main etiology of diabetes. Atherosclerosis (AS) is a chronic inflammatory disease that underlies the pathology of ischemic cardiovascular and cerebrovascular diseases. It has been documented that both endoplasmic reticulum (ER) stress and NLRP3 inflammasomes influence the progression of AS. The ER stress response in endothelial cells leads to inflammation and cell death in diabetes-related vascular diseases. ER stress also plays a key role in the onset of atherosclerosis in diabetes, which is a major consequence of endothelial dysfunction. Several independent risk factors for cardiovascular diseases, namely hyperhomocysteinemia, obesity, and dyslipidemia, as well as hyperglycemia, are also associated with ER stress, which indicates its integrating function in atherogenesis. The etiological role of low-level tissue inflammation in the formation of insulin resistance and β-cell dysfunction in type 2 diabetes is commonly recognized. Among innate immune receptors, NLRP3 plays a critical role in tissue inflammation associated with lipid overload or obesity. The research showed that ER stress is involved in inflammation and that ER plays a key role in the activation of NLRP3-inflammasomes, which trigger secretion of proinflammatory cytokines, such as IL-1β and IL-18. Metformin, an AMPK activator, inhibits ER stress and restores endothelial cell function in diabetes. Metformin inhibits NLRP3 inflammasome activation under ER stress through suppression of IL-6 and MCP-1 production induced by high glucose levels, lower TXNIP expression, and activation of autophagy via AMPK.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.

Similar content being viewed by others

REFERENCES

  1. Agouni, A., Tual-Chalot, S., Chalopin, M., et al., Hepatic protein tyrosine phosphatase 1B (PTP1B) deficiency protects against obesity-induced endothelial dysfunction, Biochem. Pharmacol., 2014, vol. 92, pp. 607–617. https://doi.org/10.1016/j.bcp.2014.10.008

    Article  CAS  PubMed  Google Scholar 

  2. Bronner, D.N., Abuaita, B.H., Chen, X., et al., Endoplasmic reticulum stress activates the inflammasome via NLRP3- and caspase-2-driven mitochondrial damage, Immunity, 2015, vol 43, pp. 451–462. https://doi.org/10.1016/j.immuni.2015.08.008

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Chai, T.F., Hong, S.Y., He, H., et al., A potential mechanism of metformin-mediated regulation of glucose homeostasis: inhibition of thioredoxin-interacting protein (TXNIP) gene expression, Cell Signal., 2012, vol. 24, pp. 1700–1705.https://doi.org/10.1016/j.cellsig.2012.04.017

  4. Cheang, W.S., Tian, X.Y., Wong, W.T., et al., Metformin protects endothelial function in diet-induced obese mice by inhibition of endoplasmic reticulum stress through 5' adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor delta pathway, Arterioscler. Thromb. Vase Biol., 2014, vol. 34, no. 4, pp. 830–836. https://doi.org/10.1161/ATVBAHA.113.301938

    Article  CAS  Google Scholar 

  5. Chen, X., Guo, X., Ge, Q., et al., ER stress activates the NLRP3 inflammasome: a novel mechanism of atherosclerosis, Oxid. Med. Cell Longev., 2019a, p. 3462530. https://doi.org/10.1155/2019/3462530

  6. Chen, C., Kassan, A., Castaceda, D., et al., Metformin prevents vascular damage in hypertension through the AMPK/ER stress pathway, Hypertens. Res., 2019b, vol. 42, no. 7, pp. 960–969. https://doi.org/10.1038/s41440-019-0212-z

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Chen, Y., Wang, J.J., Li, J., et al., Activating transcription factor 4 mediates hyperglycaemia-induced endothelial inflammation and retinal vascular leakage through activation of STAT3 in a mouse model of type 1 diabetes, Diabetologia, 2012, vol. 55, no. 9, pp. 2533–2545. https://doi.org/10.1007/sOO125-012-2594-1

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Cnop, M., Toivonen, S., Igoillo-Esteve, M., and Salpea, P., Endoplasmic reticulum stress and eIF2a phosphorylation: the Achilles heel of pancreatic β cells, Mol. Metab., 2017, vol. 6, no. 9, pp. 1024–1039. https://doi.org/10.1016/j.molmet.2017.06.001

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Davies, P.F., Civelek, M., Fang, Y., and Fleming, I., The atherosusceptible endothelium: endothelial phenotypes in complex haemodynamic shear stress regions in vivo, Cardiovasc. Res., 2013, vol. 99, no. 2, pp. 315–327. https://doi.org/10.1093/cvr/cvtl01

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. de la Roche, M., Hamilton, C., Mortensen, R., et al., Trafficking of cholesterol to the ER is required for NLRP3 inflammasome activation, J. Cell Biol., 2018, vol. 217, pp. 3560–3576. https://doi.org/10.1083/jcb.201709057

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Dong, Y., Zhang, M., Wang, S., et al., Activation of AMP-activated protein kinase inhibits oxidized LDL-triggered endoplasmic reticulum stress in vivo, Diabetes, 2010, vol. 59, no. 6, pp. 1386–1396. https://doi.org/10.2337/db09-1637

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Flamment, M., Hajduch, E., Ferre, P., and Foufelle, F., New insights into ER stress-induced insulin resistance, Trends Endocrinol. Metab., 2012, vol. 23, pp. 381–390.https://doi.org/10.1016/j.tem.2012.06.003

  13. Fonseca, S.G., Gromada, J., and Urano, F., Endoplasmic reticulum stress and pancreatic beta-cell death, Trends Endocrinol. Metab., 2011, vol. 22, no. 7, pp. 266–274.https://doi.org/10.1016/j.tem.2011.02.008

  14. Galan, M., Kassan, M., Choi, S.K., et al., A novel role for epidermal growth factor receptor tyrosine kinase and its downstream endoplasmic reticulum stress in cardiac damage and microvascular dysfunction in type 1 diabetes mellitus, Hypertension, 2012, vol. 60, pp. 71–80. https://doi.org/10.1161/HYPERTENSIONAHA.11.192500

    Article  CAS  PubMed  Google Scholar 

  15. Galan, M., Kassan, M., Kadowitz, P.J., et al., Mechanism of endoplasmic reticulum stress-induced vascular endothelial dysfunction, Biochim. Biophys. Acta, 2014, vol.1843, pp. 1063–1075.https://doi.org/10.1016/j.bbamcr.2014.02.009

  16. Gardner, B.M., Pincus, D., Gotthardt, K., et al., Endoplasmic reticulum stress sensing in the unfolded protein response, Cold Spring Harb. Perspect. Biol., 2013, vol. 5, art. a013169. https://doi.org/10.1101/cshperspect.a013169

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Ghemrawi, R., Battaglia-Hsu, S.F., and Arnold, C., Endoplasmic reticulum stress in metabolic disorders, Cells, 2018, vol. 7, no. 6, p. 63. https://doi.org/10.3390/cells7060063

    Article  CAS  PubMed Central  Google Scholar 

  18. He, Y., Hara, H., and Nunez, G., Mechanism and regulation of NLRP3 inflammasome activation, Trends Biochem. Sci., 2016, vol. 41, pp. 1012–1021. doi . 09.002https://doi.org/10.1016/j.tibs.2016

  19. Hossain, G.S., Lynn, E.G., Maclean, K.N., et al., Deficiency of TDAG51 protects against atheroclerosis by modulating apoptosis, cholesterol efflux, and peroxiredoxin-1 expression, J. Am. Heart Assoc., 2013, vol. 2, no. 3, e000134. https://doi.org/10.1161/JAHA.113.000134

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Hu, M., Phan, F., Bourron, O., et al., Steatosis and NASH in type 2 diabetes, Biochimie, 2017, vol. 143, pp. 37–41. https://doi.org/10.1016/j.biochi.2017.10.019

    Article  CAS  PubMed  Google Scholar 

  21. Hur, K.Y. and Lee, M.S., New mechanisms of metformin action: focusing on mitochondria and the gut, J. Diabetes Invest., 2015, vol. 6, no. 6, pp. 600–609. https://doi.org/10.1111/jdi.12328

    Article  CAS  Google Scholar 

  22. Inagi, R., Ishimoto, Y., and Nangaku, M., Proteostasis in endoplasmic reticulum—new mechanisms in kidney disease, Nat. Rev. Nephrol., 2014, vol. 10, no. 7, pp. 369–378. https://doi.org/10.1038/nrneph.2014.67

    Article  CAS  PubMed  Google Scholar 

  23. Incalza, M.A., D’Oria, R., Natalicchio, A., et al., Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases, Vasc. Pharmacol., 2018, vol. 100, pp. 1–19. https://doi.org/10.1016/j.vph.2017.05.005

    Article  CAS  Google Scholar 

  24. Jamwal, S. and Sharma, S., Vascular endothelium dysfunction: a conservative target in metabolic disorders, Inflamm. Res., 2018, vol. 67, pp. 391–405. https://doi.org/10.1007/s00011-018-1129-8

    Article  CAS  PubMed  Google Scholar 

  25. Kim, S., Joe, Y., Jeong, S.O., et al., Endoplasmic reticulum stress is sufficient for the induction of IL-1 beta production via activation of the NF-kappa B and inflammasome pathways, Innate Immun., 2014, vol. 20, pp. 799–815. https://doi.org/10.1177/1753425913508593

    Article  CAS  PubMed  Google Scholar 

  26. Kornfeld, O.S., Hwang, S., Disatnik, M.H., et al., Mitochondrial reactive oxygen species at the heart of the matter: new therapeutic approaches for cardiovascular diseases, Circ. Res., 2015, vol. 116, pp. 1783–1799. https://doi.org/10.1161/CIRCRESAHA.116.305432

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Lebeaupin, C., Proics, E., de Bieville, C.H., et al., ER stress induces NLRP3 inflammasome activation and hepatocyte death, Cell Death Dis., 2015, vol. 6, e1879. https://doi.org/10.1038/cddis.2015.248

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Lee, H.M., Kim, J.J., Kim, H.J., et al., Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes, Diabetes, 2013, vol. 62, pp. 194–204. https://doi.org/10.2337/db12-0420

    Article  CAS  PubMed  Google Scholar 

  29. Lenna, S., Han, R., and Trojanowska, M., Endoplasmic reticulum stress and endothelial dysfunction, IUBMB Life, 2014, vol. 66, no. 8, pp. 530–537. https://doi.org/10.1002/iub.1292

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Lerner, A.G., Upton, J.P., Praveen, P.V., et al., IRE1 a induces thioredoxin-interacting protein to activate the NLRP3 inflammasome and promote programmed cell death under irremediable ER stress, Cell Metab., 2012, vol. 16, pp. 250–264. https://doi.org/10.1016/j.cmet.2012.07.007

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Li, A., Zhang, S., Li, J., et al., Metformin and resveratrol inhibit drp1-mediated mitochondrial fission and prevent ER stress-associated NLRP3 inflammasome activation in the adipose tissue of diabetic mice, Mol. Cell Endocrinol., 2016, vol. 434, pp. 36–47. https://doi.org/10.1016/j.mce.2016.06.008

    Article  CAS  PubMed  Google Scholar 

  32. Liang, B., Wang, S., Wang, Q., et al., Aberrant endoplasmic reticulum stress in vascular smooth muscle increases vascular contractility and blood pressure in mice deficient of AMP-activated protein kinase-α 2 in vivo, Arterioscler. Thromb. Vasc. Biol., 2013, vol. 33, pp. 595–604. https://doi.org/10.1161/ATVBAHA.112.300606

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Lisa, S., Domingo, B., Martinez, J., et al., Failure of prion protein oxidative folding guides the formation of toxic transmembrane forms, J. Biol. Chem., 2012, vol. 287, pp. 36693–36701. https://doi.org/10.1074/jbc.M112.398776

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Liu, Q., Zhang, D., Hu, D., et al., The role of mitochondria in NLRP3 infiammasome activation, Mol. Immunol., 2018, vol. 103, pp. 115–124. https://doi.org/10.1016/j.molimm.2018.09.010

    Article  CAS  PubMed  Google Scholar 

  35. Lytrivi, M., Castell, A.L., Poitout, V., and Cnop, M., Recent insights into mechanisms of β-cell lipo- and glucolipotoxicity in type 2 diabetes, J. Mol. Biol., 2020, vol. 432, no. 5, pp. 1514–1534. https://doi.org/10.1016/j.jmb.2019.09.016

    Article  CAS  PubMed  Google Scholar 

  36. Maamoun, H., Zachariah, M., McVey, J.H., et al., Heme oxygenase (HO)-1 induction prevents endoplasmic reticulum stress-mediated endothelial cell death and impaired angiogenic capacity, Biochem. Pharmacol., 2017, vol. 127, pp. 46–59. https://doi.org/10.1016/j.bcp.2016.12.009

    Article  CAS  PubMed  Google Scholar 

  37. Maamoun, H., Abdelsalam, S.S., Zeidan, A., et al., Endoplasmic reticulum stress: a critical molecular driver of endothelial dysfunction and cardiovascular disturbances associated with diabetes, Int. J. Mol. Sci., 2019a, vol. 20, no. 7, p. 1658. https://doi.org/10.3390/ijms20071658

    Article  CAS  PubMed Central  Google Scholar 

  38. Maamoun, H., Benameur, T., Pintus, G., et al., Crosstalk between oxidative stress and endoplasmic reticulum (ER) stress in endothelial dysfunction and aberrant angiogenesis associated with diabetes: a focus on the protective roles of heme oxygenase (HO)-1, Front. Physiol., 2019b, vol. 10, p. 70. https://doi.org/10.3389/fphys.2019.00070

    Article  PubMed  PubMed Central  Google Scholar 

  39. Misawa, T., Takahama, M., Kozaki, T., et al., Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome, Nat. Immunol., 2013, vol. 14, pp. 454–460. https://doi.org/10.1038/ni.2550

    Article  CAS  PubMed  Google Scholar 

  40. Mohan, S., Rani, P.R.M., Brown, L., et al., Endoplasmic reticulum stress: a master regulator of metabolic syndrome, Eur. J. Pharmacol., 2019, vol. 860, p. 172553. https://doi.org/10.1016/j.ejphar.2019.172553

    Article  CAS  PubMed  Google Scholar 

  41. Muller, C., Salvayre, R., Negre-Salvayre, A., and Vindis, C., HDLs inhibit endoplasmic reticulum stress and autophagic response induced by oxidized LDLs, Cell Death Differ., 2011, vol. 18, no. 5, pp. 817–828. https://doi.org/10.1038/cdd.2010.149

    Article  CAS  PubMed  Google Scholar 

  42. Oslowski, C.M., Hara, T., O’Sullivan-Murphy, B., et al., Thioredoxin-interacting protein mediates ER stress-induced B cell death through initiation of the inflammasome, Cell Metab., 2012, vol. 16, pp. 265–273. https://doi.org/10.1016/j.cmet.2012.07.005

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Owen, C., Lees, E.K., Grant, L., et al., Inducible liver-specific knockdown of protein tyrosine phosphatase 1B improves glucose and lipid homeostasis in adult mice, Diabetologia, 2013, vol. 56, pp. 2286–2296. https://doi.org/10.1007/s00125-013-2992-z

    Article  CAS  PubMed  Google Scholar 

  44. Ozcan, L. and Tabas, I., Role of endoplasmic reticulum stress in metabolic disease and other disorders, Ann. Rev. Med., 2012, vol. 63, pp. 317–328.

    Article  CAS  PubMed  Google Scholar 

  45. Pushkarev, V.M., Sokolova, L.K., Pushkarev, V.V., and Tronko, M.D., The role of AMPK and mTOR in the development of insulin resistance and type 2 diabetes. The mechanism of metformin action, Probl. Endocrin. Pathol., 2016, vol. 3, pp. 77–90.

    Article  Google Scholar 

  46. Shi, C.S., Shenderov, K., Huang, N.N., et al., Activation of autophagy by inflammatory signals limits IL-1b production by targeting ubiquitinated inflammasomes for destruction, Nat. Immunol., 2012, vol. 13, pp. 255–263. https://doi.org/10.1038/ni.2215

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Sokolova, L.K., Pushkarev, V.M., Belchina, Y.B., et al., Effect of combined treatment with insulin and metformin on 5'AMP-activated protein kinase activity in lymphocytes of diabetic patients, Dopov. Nac. Akad. Nauk Ukr., 2018, vol. 5, pp. 100–104. https://doi.org/10.15407/dopovidi2018.05.100

    Article  CAS  Google Scholar 

  48. Sokolova, L.K., Pushkarev, V.M., Pushkarev, V.V., et al., Diabetes mellitus and atherosclerosis. The role of inflammatory processes in pathogenesis, Mezhdunarod. Endokrinol. Zh., 2017, vol. 13, no. 7, pp. 486–498.

    Google Scholar 

  49. Son, S.M. Reactive oxygen and nitrogen species in pathogenesis of vascular complications of diabetes, Diabetes Metab. J., 2012, vol. 36, pp. 190–198. https://doi.org/10.4093/dmj.2012.36.3.190

    Article  PubMed  PubMed Central  Google Scholar 

  50. Tabas, I., The role of endoplasmic reticulum stress in the progression of atherosclerosis, Circ. Res., 2010, vol. 107, no. 7, pp. 839–850. doi . 224766https://doi.org/10.1161/CIRCRESAHA.110

  51. Talty, A., Deegan, S., Ljujic, M., et al., Inhibition of IRE1alpha RNase activity reduces NLRP3 inflammasome assembly and processing of pro-IL1beta, Cell Death Dis., 2019, vol. 10, p. 622. https://doi.org/10.1038/s41419-019-1847-z

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Thon, M., Hosoi, T., Yoshii, M., and Ozawa, K., Leptin induced GRP78 expression through the PI3K-mTOR pathway in neuronal cells, Sci. Rep., 2014, vol. 4, p. 7096. https://doi.org/10.1038/srep07096

    Article  PubMed  PubMed Central  Google Scholar 

  53. Tronko, N.D., Pushkarev, V.M., Sokolova, L.K., et al., Molecular Mechanisms of Pathogenesis of Diabetes and Its Complications, Kyiv: Medkniga, 2018.

    Google Scholar 

  54. Tufanli, O., Telkoparan Akillilar, P., Acosta-Alvear, D., et al., Targeting IRE1 with small molecules counteracts progression of atherosclerosis, Proc. Natl. Acad. Sci. U. S. A., 2017, vol. 114, pp. E1395–E1404. https://doi.org/10.1073/pnas.1621188114

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Vandanmagsar, B., Youm, Y.H., Ravussin, A., et al., The NLRP3 inflammasome instigate obesity-induced inflammation and insulin resistance, Nat. Med., 2011, vol. 15, pp. 179–188. https://doi.org/10.1038/nm.2279

    Article  CAS  Google Scholar 

  56. Walter, P. and Ron, D., The unfolded protein response: from stress pathway to homeostatic regulation, Science, 2011, vol. 334, pp. 1081–1086. https://doi.org/10.1126/science.1209038

    Article  CAS  PubMed  Google Scholar 

  57. Wang, Y.I., Bettaieb, A., Sun, C., et al., Triglyceride-rich lipoprotein modulates endothelial vascular cell adhesion molecule (VCAM)-1 expression via differential regulation of endoplasmic reticulum stress, PLoS One, 2013, vol. 8, no. 10, e78322. https://doi.org/10.1371/journal.pone.0078322

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Ye, J., Mechanisms of insulin resistance in obesity, Front. Med., 2013, vol. 7, no. 1, pp. 14–24. https://doi.org/10.1007/s11684-013-0262-6

    Article  PubMed  PubMed Central  Google Scholar 

  59. Zhou, J., Massey, S., Story, D., and Li, L., Metformin: an old drug with new applications, Int. J. Mol. Sci., 2018, vol. 19, no. 10, p. 2863. https://doi.org/10.3390/ijms19102863

    Article  CAS  PubMed Central  Google Scholar 

  60. Zhou, R., Tardivel, A., Thorens, B., et al., Thioredoxin-interacting protein links oxidative stress to inflammasome activation, Nat. Immunol., 2010, vol 11, pp. 136–140. https://doi.org/10.1038/ni.1831

    Article  CAS  PubMed  Google Scholar 

  61. Zhou, Y., Tong, Z., Jiang, S., et al., The roles of endoplasmic reticulum in NLRP3 inflammasome activation, Cell, 2020, vol. 9, no. 5, p. 1219. https://doi.org/10.3390/cells9051219

    Article  CAS  Google Scholar 

  62. Zoungas, S., Chalmers, J., Ninomiya, T., et al., Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds, Diabetologia, 2012, vol. 55, no. 3, pp. 636–643. https://doi.org/10.1007/s00125-011-2404-1

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

The article was prepared within the budget funding of the National Academy of Medical Sciences of Ukraine according to the plan of research work of the Komisarenko Institute of Endocrinology and Metabolism of the National Academy of Sciences of Ukraine.

Author information

Authors and Affiliations

  1. Komisarenko Institute of Endocrinology and Metabolism, National Academy of Sciences of Ukraine, 04114, Kyiv, Ukraine

    V. V. Pushkarev, L. K. Sokolova, O. I. Kovzun, V. M. Pushkarev & M. D. Tronko

Authors
  1. V. V. Pushkarev
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. K. Sokolova
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. O. I. Kovzun
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. V. M. Pushkarev
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. D. Tronko
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to V. M. Pushkarev.

Ethics declarations

The authors declare that they have no conflicts of interest. This article does not contain any studies involving animals or human participants performed by any of the authors.

Additional information

Translated by K. Lazarev

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pushkarev, V.V., Sokolova, L.K., Kovzun, O.I. et al. The Role of Endoplasmic Reticulum Stress and NLRP3 Inflammasomes in the Development of Atherosclerosis. Cytol. Genet. 55, 331–339 (2021). https://doi.org/10.3103/S0095452721040113

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.3103/S0095452721040113

Keywords:

Search

Navigation